BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37182132)

  • 21. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress.
    Yao JY; Chen JK
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):310-5. PubMed ID: 21075072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
    Helton ES; Zhang J; Chen X
    Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P63 regulates tubular formation via epithelial-to-mesenchymal transition.
    Zhang Y; Yan W; Chen X
    Oncogene; 2014 Mar; 33(12):1548-57. PubMed ID: 23542170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma.
    Herfs M; Hubert P; Suarez-Carmona M; Reschner A; Saussez S; Berx G; Savagner P; Boniver J; Delvenne P
    Am J Pathol; 2010 Apr; 176(4):1941-9. PubMed ID: 20150431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of PLA Method for Detection of p53/p63/p73 Complexes in Situ in Tumour Cells and Tumour Tissue].
    Hrabal V; Nekulová M; Nenutil R; Holčaková J; Coates PJ; Vojtěšek B
    Klin Onkol; 2017; 30(Supplementum1):159-162. PubMed ID: 28471195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
    King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
    Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    Helton ES; Zhu J; Chen X
    J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.
    Bernassola F; Oberst A; Melino G; Pandolfi PP
    Oncogene; 2005 Oct; 24(46):6982-6. PubMed ID: 16007146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic Intra-p53 Family Member Interactions in Human Cancers.
    Ferraiuolo M; Di Agostino S; Blandino G; Strano S
    Front Oncol; 2016; 6():77. PubMed ID: 27066457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.
    Sbisà E; Mastropasqua G; Lefkimmiatis K; Caratozzolo MF; D'Erchia AM; Tullo A
    Cell Cycle; 2006 Jan; 5(2):205-12. PubMed ID: 16410722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of p63 in Development, Tumorigenesis and Cancer Progression.
    Bergholz J; Xiao ZX
    Cancer Microenviron; 2012 Dec; 5(3):311-22. PubMed ID: 22847008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p63 isoforms regulate metabolism of cancer stem cells.
    D'Aguanno S; Barcaroli D; Rossi C; Zucchelli M; Ciavardelli D; Cortese C; De Cola A; Volpe S; D'Agostino D; Todaro M; Stassi G; Di Ilio C; Urbani A; De Laurenzi V
    J Proteome Res; 2014 Apr; 13(4):2120-36. PubMed ID: 24597989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
    Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
    Paull AC; Whikehart DR
    Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural diversity of p63 and p73 isoforms.
    Osterburg C; Dötsch V
    Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.